Abstract:Summary Background Among the Omicron sublineages that have emerged, BA.1, BA.2, BA.5, and their related sublineages have resulted in the largest number of infections. While recent studies demonstrated that all Omicron sublineages robustly escape neutralizing antibody response, it remains unclear on whether these Omicron sublineages share any pattern of evolutionary trajectory on their replication efficiency and intrinsic pathogenicity along the respiratory tract. Methods We compared the virological features, replication capacity of dominant Omicron sublineages BA.1, BA.2 and BA.5 in the human nasal epithelium, and characterized their pathogenicity in K18-hACE2, A129, young C57BL/6, and aged C57BL/6 mice. Findings We found that BA.5 replicated most robustly, followed by BA.2 and BA.1, in the differentiated human nasal epithelium. Consistently, BA.5 infection resulted in higher viral gene copies, infectious viral titres and more abundant viral antigen expression in the nasal turbinates of the infected K18-hACE2 transgenic mice. In contrast, the Omicron sublineages are continuously attenuated in lungs of infected K18-hACE2 and C57BL/6 mice, leading to decreased pathogenicity. Nevertheless, lung manifestations remain severe in Omicron sublineages-infected A129 and aged C57BL/6 mice. Interpretation Our results suggested that the Omicron sublineages might be gaining intrinsic replication fitness in the upper respiratory tract, therefore highlighting the importance of global surveillance of the emergence of hyper-transmissive Omicron sublineages. On the contrary, replication and intrinsic pathogenicity of Omicron is suggested to be further attenuated in the lower respiratory tract. Effective vaccination and other precautions should be in place to prevent severe infections in the immunocompromised populations at risk. Funding A full list of funding bodies that contributed to this study can be found in the Acknowledgements section.

Competitive fitness and homologous recombination of SARS‐CoV‐2 variants of concern

Corrigendum To: Genomic Diversity of Severe Acute Respiratory Syndrome–Coronavirus 2 in Patients with Coronavirus Disease 2019

The Discovery of a Recombinant SARS2-like CoV Strain Provides Insights into SARS and COVID-19 Pandemics

The nuts and bolts of recombination in the generation of SARS-CoV-2 variants; from XA to XBB

The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2

Genomic epidemiology reveals early transmission of SARS-CoV-2 and mutational dynamics in Nanning, China

SARS-CoV-2 variant biology: immune escape, transmission and fitness

Comparative analysis of SARS‐CoV‐2 Omicron BA.2.12.1 and BA.5.2 variants

Cross-species tropism and antigenic landscapes of circulating SARS-CoV-2 variants

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape

Infectivity of pseudotyped SARS‐CoV‐2 variants of concern in different human cell types and inhibitory effects of recombinant spike protein and entry‐related cellular factors

Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events

Evolutionary Dynamics of the Severe Acute Respiratory Syndrome Coronavirus 2 Genomes

Quasispecies of SARS-CoV-2 revealed by single nucleotide polymorphisms (SNPs) analysis

The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5

Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta

Competition of SARS-CoV-2 variants on the pandemic transmission dynamics

On the Origin and Continuing Evolution of SARS-CoV-2

Human Airway and Nasal Organoids Reveal Escalating Replicative Fitness of SARS-CoV-2 Emerging Variants.

Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages

Possible Recombination Between Two Variants of Concern in a COVID-19 Patient